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Abstract: Innovation and R&D are becoming a prominent part of policies of countries and transnational 
unions such as the European Union. This is shown in strategy “Europe 2020” established by EU 
which prompts member states to invest 3 % of their GDP in R&D. R&D expenditure is an important 
indicator of innovation performance of a country. However, it is not only important to look at R&D 
expenditure as one aggregate indicator, but to also consider the contributions of various innovation 
actors to R&D funding. Since fi rms are known to be the main innovation actor that creates the 
biggest amount of innovation in national innovation system, the paper is focused on fi nancing of 
business R&D. The aim of the paper is to examine business R&D funding from resources of main 
innovation actors and to analyze the impact of public support of R&D on private R&D investment 
in EU member states. The research is based on descriptive statistics as well as panel regression 
and correlation analysis and cluster analysis of 28 EU member states. Our results suggest that the 
main source used to fund business R&D comes from business sector, followed by public support 
and resources from abroad. The cluster analysis resulted in four clusters based on the structure of 
business R&D fi nancing in the EU countries. The analysis of substitution effect of public support of 
R&D suggests that public support has a positive effect on private investment in business R&D, with 
the raise of public support for business R&D of 0.1011 % GDP resulting in 1 % increase in business 
funded R&D expenditure.
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Introduction
Many authors consider innovation to be 
the key element of economic growth and 
competitiveness of fi rms (Distanont & 
Khongmalai, 2018; Kuncoro & Suriani, 
2018) and countries (Akis, 2015; Ciocanel & 
Pavalesce, 2015; Akcali & Sismanoglu, 2015; 
Krstić, Stanišić, & Radivojević, 2016; Şener & 
Saridoğan, 2011). Even though research and 
development (furthermore just “R&D”) and 
innovation are not the same thing, R&D is 
a crucial part of innovation (Edquist, 2006). The 
importance of R&D is shown in the fact that one 
of the main priorities of the EU strategy “Europe 
2020” is the increase of R&D expenditure in the 
EU member states (European Commission, 
2010). However, we maintain that it is not 
only important to monitor R&D expenditure as 
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one aggregate indicator, but to also look at it 
incrementally from the point of involvement of 
various innovation actors in R&D funding. Since 
fi rms are considered to be the key innovation 
actor (Eggink, 2013), we decided to examine the 
fi nancing of business R&D from various sources 
of funds (business, government, university, 
non-profi t organization funds and funds from 
abroad). Many fi rms encounter the problem of 
lack of fi nancial resources needed to launch 
innovation activities. Therefore, fi rms tend to try 
and obtain fi nancial resources externally , e.g. 
through public support (Spielkamp & Rammer, 
2009). However, public support of innovation 
does not always have a positive effect on 
private R&D investment and may crowd out 
private investments (Choi & Lee, 2017; Marino 
et al., 2016; David, Hall, & Toole, 2000). 
The aim of the paper is to examine funding 
of business R&D from resources of main 
innovation actors and to analyze the impact of 
public support on private R&D investment in the 
EU member states. The paper is focused on 
summarizing the theoretical fi ndings of authors 
related to impact of various innovation actors 
on business innovation as well as the impact 
of public support on business R&D investment. 
EU countries are divided into clusters based 
on their structure of business R&D funding and 
occurrence of the substitution effect of public 
support is tested through panel regression and 
correlation analysis.
1. Literature Review
Despite the importance of innovation and R&D 
and its impact on growth and competitiveness, 
many fi rms are not involved in innovation 
activities (as suggested by the results of e.g. 
OECD survey from 2017). There are several 
barriers hindering a fi rm’s decision to launch 
an innovation project. Spielkamp and Rammer 
(2009) divide factors that hamper the success of 
the innovation process into several categories 
– cost, economic risk and profi t opportunities; 
lack of internal and external fi nancial resources; 
knowledge and human capital; legal and 
bureaucratic burdens; and intercompany 
restrictions and constraints. D’Este et al. (2012) 
state that barriers fi rms encounter are often 
related to fi nancial obstacles. These statements 
are in line with practice, since survey carried out 
by the European Commission in 2014 found that 
the main reasons fi rms decided not to undertake 
innovation activities included lack of internal 
fi nancial resources; lack of skilled employees 
in a fi rm; lack of motivation to innovate; low 
demand on market; previous innovation; lack 
of competition (European Commission, 2014). 
These studies lead us to believe that one of the 
key barriers of innovation activities within fi rms 
is the lack of fi nancial resources needed to 
introduce innovation. Firms do not always have 
enough internal fi nancial resources to launch 
in-house innovation projects and they therefore 
turn to providers of external funds (Wang et al., 
2016).
Access of a fi rm to fi nancial resources 
varies based on the size of a fi rm as well as 
its specialization (OECD, 2004). External 
fi nancial resources used to fund innovation and 
R&D activities can be obtained from various 
economic subjects. Most often, fi rms receive 
these resources from other businesses (e.g. 
banks).
However, private investors often avoid 
investing in innovation projects for several 
reasons. Reasoning of these investors often 
includes:
 the fact that the innovation process is an 
uncertain activity, which means that it is 
diffi cult for an investor to evaluate potential 
of innovation projects;
 earnings from innovation process are 
extremely skewed, evidence suggests 
that earnings from innovation have the 
characteristics of Pareto’s distribution, 
which leads to diffi culties in applying 
standard methods of evaluation of 
innovation projects;
 the innovator has more information than 
the investor, therefore the investor cannot 
evaluate the necessary inputs and possible 
outputs of innovation projects;
 fi rms involved in innovation activities 
have high share of intangible assets – 
knowledge is represented in human capital 
(employees), which means that if an 
employee leaves his job, fi rm would lose 
an important source of innovation process 
(Kerr & Nanda, 2011).
Bekker (2013) partially agrees with this 
reasoning, while he adds that sunk cost, long 
time lags between cost and profi t, adverse 
selection and moral hazard also discourage 
investors from funding innovation projects. 
These reasons often stop private investors from 
investing in innovative fi rms. Therefore, other 
actors step in to fi ll fi nancial gap innovating fi rms 
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often encounter. Even though the public sector 
often fulfi ls the role of supporting innovative 
fi rms in need of funding, there are also other 
subjects that contribute to funding of business 
R&D. According to OECD (2015), business 
R&D can be funded by fi ve main innovation 
actors – business enterprises, government, 
higher education institutions, private non-profi t 
organizations and by institutions from abroad. 
These innovation actors help fund private 
innovation projects and overcome barriers 
hindering innovation. For example, universities 
mitigate the effect of sunk cost, since they endure 
the cost of “mistakes” instead of innovative 
fi rms. The collaboration with universities also 
helps reduce uncertainty stemming from 
innovation projects, since university employees 
can explore various options beforehand and 
guarantee that a fi rm gets good results. Time 
lags can also be shortened, since universities 
are capable of carrying out R&D in the initial 
stages of innovation, which shortens time lags 
of innovation activities in a fi rm (Bekker, 2013). 
The collaboration between innovation actors 
stems from Triple Helix model focused on 
interactions between these actors. Within the 
Triple Helix model, academy (higher education 
institutions, universities), government and 
business enterprises are three pillars that work 
together in order to create or discover new 
knowledge, technologies, products or services 
(Vaivode, 2015). Firms are forced to cooperate 
with universities and public research institutions 
in order to expand their innovation activities 
beyond their own potential. In this instance, 
we can consider these organizations to be 
a crucial source of business innovation (Moon, 
Mariadoss, & Johnson, 2017).
However, despite these benefi ts 
collaboration with other innovation actors 
brings to fi rms, it is questionable as to why 
these subjects cooperate with innovative fi rms 
and support them. The most important source 
of fund of innovative fi rms, outside of private 
investments, is public sector. Even though 
universities and private non-profi t organizations 
also support innovative fi rms, their support is 
mainly non-fi nancial, in a form of cooperation 
and joint research (Permann & Walsh, 2007; 
Rybnicek & Königsgruber, 2018; Abidin et al., 
2014).
The main reasoning behind the involvement 
of public sector (and other innovation actors) in 
business R&D funding is the fact that otherwise 
market would invest less in innovation 
activities than is socially acceptable. There 
are microeconomic and macroeconomic 
reasons of public interventions in the area 
of R&D. Microeconomic justifi cation of state 
interventions in R&D&I activities stems from 
the theory of market failures and characteristics 
of R&D that were introduced by neoclassical 
economists. According to this theory, innovation 
is affected by multiple market failures, of which 
some lead to insuffi cient and some to excessive 
R&D investment. However, economists mostly 
agree that in the absence of public support, 
market would engage in insuffi cient amount of 
innovation activities. Intellectual property rights 
and R&D subsidies funded by the state should 
therefore stimulate innovation (Leibowicz, 
2018). Microeconomic reasoning for public 
support of R&D includes arguments such as:
 R&D has the characteristics of public 
goods, since it is non-rivalrous and non-
excludable;
 R&D creates externalities in the form of 
knowledge spillovers, which leads to R&D 
creating positive external effects that cannot 
be internalized by fi rms, meaning that the 
social rate of return of knowledge creation 
is higher than the private rate of return of 
a fi rm;
 limited ability of reaping benefi ts of R&D 
related to knowledge spillovers;
 asymmetric information and problematic 
access to fi nance;
 coordination problems (Martin & Scott, 
2000; Arrow, 1962; Hud & Hussiner, 2015; 
Jaumotte & Pain, 2005; Falk, 2007).
However, some authors say that market 
failures are not the only and not even the 
most signifi cant reason of public interventions 
in innovation activities. While these authors 
do not question the existence of market failures, 
they state that market failures themselves 
do not provide evidence for adequate analysis 
and empirical basis of innovation policy. 
Public support of innovation is therefore not 
appropriate to be justifi ed by market failures 
based on unrealistic assumptions of perfect 
competition and perfect information, but on 
the fact that turbulent world dominated by 
innovation is characterized by uncertainty 
(Dodgson et al., 2011). Chaminade and 
Edquist (2006) agree with this statement and 
add that the biggest advantage of neoclassical 
approach representing market failures is its 
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simplicity. However, they think that political 
implications stemming from the theory of market 
failures are not instrumental in policy creation. 
These implications do not suggest the size of 
subsidies or other interventions, or the areas 
in which the state should intervene. Market 
failure approach is therefore too abstract to 
provide a guide to create innovation policies. 
There are also cases when policy makers try 
to intervene and correct a market failure, which 
leads to creation of additional failures, e.g. by 
introducing intellectual property law to solve the 
problem of return on resources, policy makers 
create barriers to the fl ow of information, which 
leads to creation of additional market failures.
According to the macroeconomic approach, 
the main justifi cation of public interventions in the 
area of R&D&I is potential impact of innovation 
on economic growth. Lundvall (2010) states 
that the main reason government contributes 
to innovation policy is the assumption that 
innovation is a key element of national 
economic growth. Government plays a key 
role in the support of innovation, helps sustain 
appropriate environment for development of 
innovation, invests in innovation activities, 
helps overcome certain innovation barriers 
and ensures that innovations contribute to 
accomplishing the main goals of public policy, 
such as economic growth, which in turn leads 
to other benefi ts, such as reduction of public 
debt (Knapková, Kiaba, & Hudec, 2019). Even 
though innovation policy is usually seen in 
a narrow view – policy supporting business 
R&D, venture capital funding, etc. – this 
policy is usually only a part of a set of policies 
that affect innovation performance. Thus, 
government needs to consider how innovation 
and innovation policies affect other public goals 
and complementary policies that need to be 
installed in order to accomplish all public goals.
From direct funding of education and R&D 
to various regulatory frameworks, public policy 
affects business innovation activities. However, 
effectiveness of public support and its impact on 
private R&D&I investment is the subject of many 
discussions. Despite many benefi ts of public 
support for innovation, there are also certain 
restrictions known as public failures. Guellec 
and van Pottelsberghe (2000) introduce three 
examples in which policies aimed at stimulation 
of R&D may have negative effects no private 
R&D investment:
 the crowding out effect through prices;
 the substitution effect;
 the allocation deformations.
Public R&D expenditure may crowd out 
private investments through increase of 
demand, which leads to an increase in the price 
of R&D. In cases where cost of R&D increases, 
fi rms will allocate their fi nancial resources in 
other activities, which will lead to an increase of 
total volume of R&D even though “real volume” 
(measured by the number of researchers) 
will be lower and less economically effective. 
Another argument is that public funding of 
innovation directly replaces private investment 
in innovation. This phenomenon is known as 
substitution effect described as a situation 
when fi rms decide to replace investment in 
innovation from their own resources with 
programs provided by public support (e.g. from 
EU structural funds) (Némethová, Širaňová, & 
Šipikal, 2019). Public support for R&D&I can 
also be ineffective when the public support is 
allocated into projects less effi ciently than if 
this allocation was made by the market, which 
leads to deformation in the area of allocation 
of resources between various research fi elds 
(Guellec & van Pottelsberghe, 2000).
The impact of the substitution and crowding 
out effect of public support for R&D&I is 
a center of attention of many authors. Guo, 
Guo and Jiang (2016) state that analyses of 
effects of governments programs for support of 
R&D do not show uniform results. It was proven 
that fi rms receiving government subsidies 
achieve higher productivity and profi tability. It 
was also shown that these fi rms grow faster, 
have better access to external funding, invest 
a larger amount of fi nancial resources into 
R&D and show higher social rate of return. 
However, many studies suggest that public 
programs to support R&D do not stimulate 
fi rms’ performance or only have limited positive 
effect on business R&D expenditure with the 
exception of small businesses. Several studies 
show that government R&D subsidies crowd 
out private R&D investment, which leads to 
a decrease in social welfare and growth, e.g. 
Marino et al. (2016) found that substitution 
effect between public and private R&D 
expenditure occurs mostly within medium-size 
fi rms. Some authors concluded that although 
public subsidies do not crowd out private R&D 
investment, they do not stimulate it either 
(González & Pazó, 2008). Other authors state 
that the effect of additionality only occurs in 
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small fi rms (Lööf & Hesmati, 2005). However, 
many other authors (Carboni, 2017; Choi 
& Lee, 2017; Liu, Li, & Li, 2016; Ali-Yrkkö, 
2005; Sadraoui & Zina, 2009; Afcha & López, 
2014) found that subsidy programs aimed at 
supporting R&D stimulate private investment 
in R&D in fi rms. The occurrence of substitution 
effect of public support of R&D therefore differs 
based on the region and industry in which a fi rm 
operates (Jin, Shang, & Xu, 2018; Capron & 
van Pottelsberghe, 1997).
2. Methodology and Data
The paper is aimed at the examination of 
business R&D expenditure from the point of 
view of sources of fund used to fi nance it and 
the analysis of occurrence of the substitution 
effect of public support for R&D in the EU. The 
main research questions of the paper are as 
follows:
RQ1: To what extent do innovation actors 
other than business enterprises invest in 
business R&D in the EU countries and contribute 
to structure of business R&D expenditure?
RQ2: Does government spending on 
business R&D lead to increase of business 
R&D investment in the EU countries?
The analysis uses secondary data obtained 
from Eurostat database as well as secondary 
data from OECD database “Innovation 
Indicators”. The key indicator examined in the 
paper is expenditure on R&D (GERD – Gross 
Domestic Expenditure on R&D) of the EU 
member states. OECD (2015) divides these 
expenditures based on two aspects:
 GERD by sector of performance – stemming 
from who spent the expenditure on R&D;
 GERD by source of fund – stemming from 
the fi nancial resource that was used to fund 
R&D activity.
These two aspects are not always identical, 
seeing that a subject can fund its innovation 
activity from other funds, e.g. a fi rm can spend 
expenditure on R&D funded by public sector 
(e.g. by public support in a form of a subsidy 
or grant). The paper is focused on the second 
aspect of R&D expenditure – R&D expenditure 
based on the fi nancial sources used to fund 
R&D activity. Eurostat differentiates fi ve 
possible fi nancial resources that can be used to 
fund R&D: resources of business enterprises, 
government, higher education institutions 
(further referred to as “universities”), private 
non-profi t organizations and resources from 
abroad. Since business enterprises are 
generally identifi ed as the key innovation actor 
involved in most R&D activities in a country, we 
focus on the fi nancial resources used to fund 
business R&D (BERD – Business Enterprise 
R&D Expenditure).
Analysis of secondary data is carried 
out using methods of descriptive statistics in 
addition to cluster analysis and panel regression 
and correlation analysis.
Descriptive statistics is carried out on the 
sample of all 28 EU member states. Descriptive 
statistics combines two different approaches:
 analysis of static data for one period (latest 
period with the available data – year 2015) 
used in order to compare contribution of 
innovation actors to business R&D funding 
in EU member states, and
 analysis of the longer time period on the 
sample of aggregate amount of business 
R&D expenditure of all EU member states 
(the aggregate value is used in order to 
achieve higher illustrative clarity of data) 
used to demonstrate development of 
sources used to fund business R&D over 
time.
Cluster analysis is also applied on the data 
of all EU member states for year 2015. We 
used hierarchic agglomerative algorithm in 
combination with the Ward method of linking. 
The results of cluster analysis are illustrated 
using dendrogram.
Regression and correlation analyses 
are applied on panel data, specifi cally on the 
sample of all 28 EU member states for the 
longer time period of 2008–2015. Regression 
analysis is based on the least squares method 
in the combination with fi xed effects model of 
cross-sectional data. Logarithms of the data 
are used in the regression analysis in order to 
achieve normal distribution of the data. Granger 
causality hypothesis is used to test causality of 
chosen variables of regression analysis.
3. Results and Discussion
Growth of R&D expenditure of member states 
is currently one of the main priorities of the EU. 
Since a big part of R&D takes places in fi rms, 
which are considered to be the key innovation 
actor, we decided to focus on examination 
of R&D expenditure spent by fi rms. Even 
though many fi rms show interest in introducing 
innovation projects, one of the main barriers of 
innovation activities is lack of internal fi nancial 
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resources. Thus, other subjects get involved 
in funding of business R&D. The contribution 
of these subjects to business R&D funding in 
2015 is illustrated in Fig. 1.
It is apparent that the level of business R&D 
expenditure spent in the EU member states 
varies considerably. While in some countries 
(e.g. Austria, Sweden or Finland) fi rms spend 
over 2 % of national GDP on R&D, in other 
countries (e.g. Cyprus, Latvia or Romania) 
this value is lower than 0.5 %. However, 
difference in the business R&D expenditure 
is not only apparent in the total amount of 
expenditure spent, but also in its structure. In 
Fig. 1: Business R&D funding from funds of innovation actors in the EU member states in 2015 (% of GDP)
Source: authors, based on data from Eurostat
Fig. 2:
Share of innovative fi rms collaborating on innovation with universities and/
or government institutions compared to business R&D expenditure spent by 
universities and government in 2015
Source: authors, based on data from Eurostat and OECD
EM_1_2020.indd   126 14.4.2020   10:12:37
1271, XXIII, 2020
Finance
almost all countries under examination (with the 
exception of Bulgaria), fi rms mostly use private 
fi nancial resources to fund their R&D activities, 
which means they mostly use their own profi t 
or resources from other private enterprises (e.g. 
commercial banks).
The second most pronounced source of 
fund regarding business R&D is foreign funds. 
However, the level of funds from abroad varies 
across EU countries. It seems that foreign 
sources used to fund business R&D are mostly 
used in countries with open economies. The 
level of public funding also shows various 
results in monitored countries. Even though the 
public support of business R&D accounts for 
a signifi cant part of business R&D expenditure 
in some countries (e.g. Hungary or Austria), 
in other countries, the use of public funding to 
support business R&D is very low. Business 
R&D funding from sources of universities and 
private non-profi t organizations shows nearly 
negligible values in all EU member states, 
which means that these institutions do not 
signifi cantly contribute to business R&D. These 
results are in line with economic theory as well 
as practice.
Considering the relation of the researched 
issue to Triple Helix model, we also decided 
to examine the share of innovative fi rms that 
used collaboration with universities and/
or government institutions in the innovation 
process. Since this data is provided by OECD, 
the data was not available for all EU countries. 
Thus, we had to remove eight countries 
(namely Romania, Bulgaria, Croatia, Lithuania, 
Malta, Cyprus, Ireland and Luxembourg) from 
this particular analysis. We also included 
the data regarding the expenditure spent on 
business R&D by universities and government 
in order to see if there is a link between these 
two variables. We can see that countries with 
the highest share of innovative fi rms using this 
form of collaboration included Slovenia, Finland 
or Greece. There are some parallels between 
the share of collaborations and the government 
and university spending on business R&D, but 
these parallels seem to be inconclusive. While 
some of the lowest government and university 
investments in business R&D happen to be 
in countries that also have very low intensity 
of collaboration (Slovakia, the Netherlands, 
Portugal, Latvia), we can also see that some 
of the countries in which we can fi nd the 
highest share of collaboration, have quite 
a low government and university spending on 
business R&D (Slovenia, Finland). However, 
the collaboration between fi rms and other 
innovation actors within the Triple Helix model 
is not always fi nancial in its nature, so we fi nd 
these results plausible.
Fig. 3:
Development of business R&D funding from funds of innovation actors 
between 2008 and 2015 (as aggregate value of the EU member states, 
in mil. EUR)
Source: authors, based on data from Eurostat
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In order to illustrate development of business 
R&D funding in the EU over a longer period, 
contributions of various innovation actors to 
business R&D expenditure is also examined 
as an aggregate value of all EU member 
states. Development over time confi rms our 
assumptions based on the static data from 
2015. Long-term dominance of business-
based funding can be seen (around 82 % of 
total business R&D expenditure with growing 
tendency over time), with foreign funds being 
the second most pronounced source used to 
fund business R&D. Public funding accounted 
for 6–7 % of total business R&D expenditure in 
the EU over period under review. Even though 
the share of external funding (from public sector 
or from abroad) has increasing tendency in 
absolute numbers, due to growth of business 
funds, the share of external funds to business 
R&D is constant on the same levels.
Based on the available data, we created 
dendrogram illustrating clusters of countries 
with similar structure of business R&D 
funding. Based on the Silhouette coeffi cient, 
average value of which is 0.4, we can state 
that algorithm of hierarchic clustering was 
chosen appropriately. Results suggest that it 
is appropriate to divide the EU member states 
into four clusters. The smallest cluster included 
two countries (Hungary and Austria), while the 
biggest cluster comprised of fourteen countries, 
including two V4 countries – Slovakia and 
Poland. These clusters suggest that structure 
of business R&D funding is similar in these 
countries. We can see some parallels between 
achieved results of cluster analysis and 
innovation performance of the EU member 
states according to Summary Innovation Index 
published by the European Commission (2019). 
Countries with higher scores of SII (especially 
Fig. 4: Dendrogram showing clusters of the EU member states based on the structure of business R&D funding in 2015
Source: authors in statistical system R based on data from Eurostat
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some of the innovation leaders) according 
to the European Commission can be found 
in one cluster, which leads us to believe that 
business R&D affects innovation performance 
of a country to a certain extent.
Average values of business R&D funding 
of resulting clusters offer several conclusions. 
Public and university support of business R&D 
can mostly be seen in Cluster 2 (comprising of 
Hungary and Austria). It is also apparent that 
the highest average value of private business 
R&D funding can be found in Cluster 4, which 
includes countries belonging to the group of 
innovation leaders according to the European 
Commission. This cluster also shows the highest 
involvement of foreign funds. Since countries in 
this cluster belong to the EU member states 
with the highest innovation performance, we 
assume that these funds (business and from 
abroad) are one of the factors of success of 
these countries in the area of innovation and 
R&D.
The occurrence of substitution effect of 
public R&D funding in the EU member states 
is examined based on the relationship between 
business and public funding of business R&D. 
Theory suggests that public support of business 
R&D may have positive or negative effect 
(so-called substitution effect) on private R&D 
investment. Thus, correlation and regression 
analysis of relationship between public and 
private business R&D expenditure is performed. 
Since many higher education institutions take 
a form of public universities, we decided to also 
examine the impact of university funding on 
business R&D.
Based on the correlation matrix, we can see 
that positive correlation can be found between 
Cluster/Source of fund Business enterprises
Govern-
ment Universities
Private 
non-profi t 
organiza-
tions
Abroad
Cluster 1 (EE, IE, LU, PL, PT, 
CY, LV, GR, SK, HR, MT, RO, 
BG, LT)
0.351
(0.185)
0.026
(0.020)
0.087
(0.110)
2.86E-04
(0.001)
4.41E-04
(0.001)
Cluster 2 (BE, SI, FI, CZ, FR, 
ES, IT, NL)
1.099
(0.437)
0.073
(0.031)
0.201
(0.114)
4.60E-04
(4.29E-04)
0.001
(0.001)
Cluster 3 (HU, AT) 1.140
(0.677)
0.242
(0.063)
0.328
(0.236)
2.66E-04
(3.76E-04)
0.001
(0.000)
Cluster 4 (SE, UK, DK, DE) 1.687
(0.463)
0.096
(0.038)
0.191
(0.075)
0.001
(0.001)
0.007
(0.001)
Source: authors based on data from Eurostat.
Note: Table contains average values with values of standard deviations being shown in parentheses (.).
Tab. 1: Average values and standard deviations of variables for each cluster of the EU member states based on the structure of business R&D funding in 2015
Business 
enterprise 
expenditure
Government 
expenditure
Higher education 
expenditure
Business enterprise expenditure 1.0000 0.5542 0.2458
Government expenditure 0.5542 1.0000 0.1899
Higher education expenditure 0.2458 0.1899 1.0000
Source: authors in econometric program EViews based on data from Eurostat
Tab. 2:
Correlation matrix of business R&D expenditure funded by business 
enterprises, government and universities in the EU member states 
between years 2008–2015
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variables. While the relationship between 
business and university funds shows negligible 
correlation, relationship between business and 
government funds suggests moderate positive 
correlation. Granger causality was furthermore 
used to determine if selected variables 
were appropriate for regression analysis, 
since correlation does not necessarily imply 
causation.
Based on the Granger causality tests, we 
can reject the hypothesis that government 
funding does not Grange cause business 
funding and that university funding does not 
Granger cause business funding. It therefore 
seems that Granger causality runs one-way 
in both cases from government and university 
(at 10 % signifi cance level) funding to business 
funding. It is therefore appropriate to perform 
regression analysis examining the impact of 
government and university funding on business 
R&D investment. In order to include possible 
time lags on this impact, we created several 
regression models including the impact of public 
and university funding invested in business 
R&D in 2013, 2014 and 2015 respectively 
on private funding of business R&D in 2015. 
This was done because the impact of public 
support for business R&D can show its impact 
not immediately, but after some time, when the 
provided fi nancial resources are actually spent 
by fi rms.
Based on the Akaike information criterion, 
we decided to closely examine model with time 
lag of one year. Model examined the impact of 
public and university funding of business R&D 
provided in period n on business investment 
Null hypothesis Observations F-Statistic Probability
GOV does not Granger Cause ENT
168
5.95178 0.0032
ENT does not Granger Cause GOV 0.80131 0.4505
UNI does not Granger Cause ENT
168
2.42721 0.0915
ENT does not Granger Cause UNI 0.48268 0.6180
Source: on data from Eurostat
T T-1 T-2
Constant -0.3820**
(-1.9135)
-0.3102
(-1.2538)
0.0817
(0.3120)
Government expenditure 0.1446*
(3.3740)
0.1011**
(2.0123)
   0.0582
   (1.0268)
Higher education expenditure -0.0191
-1.3283
0.0009
0.0496
0.0526**
2.8526
R2 0.9554 0.9520 0.9590
R2 adjusted 0.9487 0.9436 0.9504
Observations 224 196 168
Durbin Watson statistics 0.9978 1.0269 1.2184
Akaike info criterion -0.0746 -0.0781 -0.0724
Source: authors in econometric program EViews based on data from Eurostat
Note:  T-statistics are shown in parentheses (.) with pertaining signifi cance level of p-values denoted as: */**/*** on the 
signifi cance levels of 10%/5%/1%.
Tab. 3:
Results of Granger causality analysis between government and business funds 
and university and business funds based on 2 time lags in the EU member 
states in 2008–2015
Tab. 4:
Results of regression models examining the impact of university 
and government business funding R&D on private R&D investment 
with various time lags in the EU member states between 2008–2015
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in business R&D in period n+1. Based on the 
results of the model, changes in public and 
university funding explain 94.87 % of changes in 
private business R&D funding. The regression 
line of the impact of public and university 
funding on business funding is as follows:
ŷ = –0.3102 + 0.1011gov + 0.0009uni  (1)
where gov represents the coeffi cient of 
government funding and uni represents the 
coeffi cient of university funding. However, it is 
important to remark that p-value of T-statistics 
of university funding in the model suggests 
that coeffi cient is not statistically signifi cant. 
Therefore, we can only interpret the impact of 
public funding on business R&D investment. 
Results suggest that government funding has 
a positive effect on business R&D investment. 
The model shows that increase of public funded 
business R&D expenditure of 0.1011 % GDP 
causes increase in business investment in R&D 
of 1 % of GDP. We can therefore state that in this 
case, the substitution effect of public support of 
R&D&I, which occurs when fi rms replace their 
own investment in R&D by public support, does 
not occur. Thus, we can say that in the EU 
member states, public support of R&D&I has 
a positive effect on private R&D investment. 
Our conclusions are in line with results of 
many authors examining the occurrence of 
substitution effect and impact of public support 
on private R&D investment, which confi rm the 
positive effect of public support on private R&D 
investment (David, Hall, & Toole, 1999; Ali-
Yrkkö, 2005; Choi & Lee, 2017) and are partially 
in line with other studies (Aristei, Sterlacchini, 
& Venturini, 2015). Therefore, we see public 
support of business R&D&I as an important part 
of innovation and R&D funding in the EU.
Conclusions
Many studies show that innovation is one of the 
key elements of growth and competitiveness of 
fi rms. However, despite these benefi ts, some 
fi rms do not participate in innovation activities. 
One of the main reasons for this is the lack of 
fi nancial resources needed to launch innovation 
projects. Therefore, other actors contribute to 
funding of business R&D&I activities.
The aim of the paper was to examine 
funding of business R&D from resources of main 
innovation actors and to analyze the impact of 
public support on private R&D investment in the 
EU member states. Two research questions 
were set out at the beginning of research. 
First research question was answered by the 
analysis of structure of business R&D funding. 
It seems that business R&D is mostly funded 
from private resources followed by funds from 
abroad and public funds. Using cluster analysis, 
we created four clusters of EU member 
states with similar structure of business R&D 
funding. The results of cluster analysis were 
partially in line with the results of European 
Innovation Scoreboard, which suggests that 
business R&D funding is one of the factors of 
innovation performance of a country. Second 
research question was answered based on 
the correlation and regression panel analysis, 
where we found that in the EU member states, 
substitution effect of public support for R&D 
does not occur, since public funding of business 
R&D seems to have a positive effect on private 
R&D investment. The results suggest that 
increase in public funding of business R&D 
of 0.1011 % GDP causes 1 % of GDP growth 
of private R&D investment. These results are 
in line with results of many studies, as well as 
economic theory.
Achieved results provide several 
conclusions and political implications. We 
consider business R&D expenditure to be one 
of the key elements of innovation performance 
of a country, which is refl ected in the EU strategy 
Europe 2020 which accentuates growth of R&D 
expenditure as one of its main goals. Even 
though structure of business R&D expenditure 
funding varies across the EU countries, we 
consider public support of R&D&I to be an 
important part of business R&D funding. Since 
our results confi rm the positive effect of public 
support for R&D&I on private R&D investment, 
our suggestion is to intensify the public support 
of R&D&I in the EU member states and thus, 
through the leverage effect, increase private 
R&D investment. This may lead to growth of 
innovation performance and competitiveness of 
fi rms as well as countries.
Even though there are many papers 
focused on examination of the substitution and 
crowding-out effects of public support of R&D 
and innovation, not many of them take into 
account the structure of business R&D funding 
and contribution of other actors outside of 
public sector. We therefore think that one of the 
main contributions of our paper is international 
comparison of business R&D funding structure, 
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which provides interesting political implications 
at the EU level. However, we realize that our 
research is not without its restrictions. Since 
we only focused on business R&D funding, we 
did not take into account other factors that may 
impact private R&D investment. It could also be 
advisory to narrow the analysis of substitution 
effect of the public support to a certain cluster 
of the EU countries, which might provide 
more specifi c results that may result in 
recommendations benefi cial to national policy 
makers.
As the study showed, one of the biggest 
obstacles to business innovation in Slovakia is 
the lack of resources. The recommendation for 
sustainable public policy-makers is to continue 
to increase the volume of public resources 
towards public and private sector. It is also 
crucial to support academic and business 
cooperation mechanisms in terms of the 
Triple Helix model. This way, the government 
would motivate enterprises to increase R&D 
expenditure in order to support the development 
of science and research base in the country as 
a source of its innovative development.
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